Analysis: Drug industry bets on new blockbusters in 2013

LONDON/NEW YORK, Jan 16: Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow’s blockbusters in the coming 12 months. With the industry regaining some of its swagger after winning 39 new drug approvals last year – a record only beaten in 1996 – there are signs the improving trend could continue through 2013. (agencies)


Please enter your comment!
Please enter your name here